All Cosmos Bio-Tech Holding Corp (4148) - Total Assets

Latest as of December 2025: NT$4.22 Billion TWD ≈ $133.10 Million USD

Based on the latest financial reports, All Cosmos Bio-Tech Holding Corp (4148) holds total assets worth NT$4.22 Billion TWD (≈ $133.10 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check All Cosmos Bio-Tech Holding Corp (4148) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

All Cosmos Bio-Tech Holding Corp - Total Assets Trend (2010–2025)

This chart illustrates how All Cosmos Bio-Tech Holding Corp's total assets have evolved over time, based on quarterly financial data. Check All Cosmos Bio-Tech Holding Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

All Cosmos Bio-Tech Holding Corp - Asset Composition Analysis

Current Asset Composition (December 2025)

All Cosmos Bio-Tech Holding Corp's total assets of NT$4.22 Billion consist of 72.5% current assets and 27.5% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 29.0%
Accounts Receivable NT$883.13 Million 20.9%
Inventory NT$683.98 Million 16.2%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$10.76 Million 0.3%
Goodwill NT$405.00K 0.0%

Asset Composition Trend (2010–2025)

This chart illustrates how All Cosmos Bio-Tech Holding Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see All Cosmos Bio-Tech Holding Corp (4148) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: All Cosmos Bio-Tech Holding Corp's current assets represent 72.5% of total assets in 2025, an increase from 65.6% in 2010.
  • Cash Position: Cash and equivalents constituted 29.0% of total assets in 2025, up from 19.0% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 15.0% in 2010.
  • Asset Diversification: The largest asset category is accounts receivable at 20.9% of total assets.

All Cosmos Bio-Tech Holding Corp Competitors by Total Assets

Key competitors of All Cosmos Bio-Tech Holding Corp based on total assets are shown below.

Company Country Total Assets
Hubei Yihua Chemical Industry Co Ltd
SHE:000422
China CN¥47.06 Billion
Cangzhou Dahua Co Ltd
SHG:600230
China CN¥6.04 Billion
Kunming Chuan Jin Nuo Chemical Co Ltd
SHE:300505
China CN¥4.53 Billion
Itafos Corp
V:IFOS
Canada CA$819.37 Million
Guangxi Hechi Chemical Co Ltd
SHE:000953
China CN¥272.22 Million
Kyung Nong Corporation
KO:002100
Korea ₩486.46 Billion
Soquicom
SN:SOQUICOM
Chile CL$133.30 Million
CO2 Gro Inc
V:GROW
Canada CA$710.61K

All Cosmos Bio-Tech Holding Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.99 5.56 4.90
Quick Ratio 3.88 4.15 3.80
Cash Ratio 0.00 0.00 0.00
Working Capital NT$2.45 Billion NT$2.18 Billion NT$1.63 Billion

All Cosmos Bio-Tech Holding Corp - Advanced Valuation Insights

This section examines the relationship between All Cosmos Bio-Tech Holding Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.89
Latest Market Cap to Assets Ratio 0.02
Asset Growth Rate (YoY) 15.1%
Total Assets NT$4.22 Billion
Market Capitalization $65.99 Million USD

Valuation Analysis

Below Book Valuation: The market values All Cosmos Bio-Tech Holding Corp's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: All Cosmos Bio-Tech Holding Corp's assets grew by 15.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for All Cosmos Bio-Tech Holding Corp (2010–2025)

The table below shows the annual total assets of All Cosmos Bio-Tech Holding Corp from 2010 to 2025.

Year Total Assets Change
2025-12-31 NT$4.22 Billion
≈ $133.10 Million
+15.10%
2024-12-31 NT$3.67 Billion
≈ $115.64 Million
-0.09%
2023-12-31 NT$3.67 Billion
≈ $115.74 Million
-10.64%
2022-12-31 NT$4.11 Billion
≈ $129.53 Million
+38.43%
2021-12-31 NT$2.97 Billion
≈ $93.57 Million
+13.60%
2020-12-31 NT$2.61 Billion
≈ $82.37 Million
-0.95%
2019-12-31 NT$2.64 Billion
≈ $83.16 Million
-11.27%
2018-12-31 NT$2.97 Billion
≈ $93.72 Million
+10.69%
2017-12-31 NT$2.69 Billion
≈ $84.67 Million
+27.18%
2016-12-31 NT$2.11 Billion
≈ $66.58 Million
-10.08%
2015-12-31 NT$2.35 Billion
≈ $74.04 Million
-0.55%
2014-12-31 NT$2.36 Billion
≈ $74.44 Million
+21.18%
2013-12-31 NT$1.95 Billion
≈ $61.43 Million
+5.92%
2012-12-31 NT$1.84 Billion
≈ $58.00 Million
+40.06%
2011-12-31 NT$1.31 Billion
≈ $41.41 Million
+32.07%
2010-12-31 NT$995.12 Million
≈ $31.35 Million
--

About All Cosmos Bio-Tech Holding Corp

TW:4148 Taiwan Agricultural Inputs
Market Cap
$65.99 Million
NT$2.09 Billion TWD
Market Cap Rank
#20898 Global
#1279 in Taiwan
Share Price
NT$31.15
Change (1 day)
+2.81%
52-Week Range
NT$30.30 - NT$46.30
All Time High
NT$126.05
About

All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia and internationally. The company offers bio-chemical fertilizers, as well as offers water reutilization services. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In add… Read more